COVID Antiviral Paxlovid Provides “No Significant Benefit” to Vaccinated Seniors
Paxlovid, the antiviral drug that became the go-to treatment for SARS-CoV-2 infections during the pandemic, did not reduce hospitalizations or death in older adults who had gotten COVID-19 shots, according to a new study published in the Journal of the American Medical Association (JAMA) last month. Researchers who tested the COVID treatment Paxlovid (nirmatrelvir-ritonavir) on […]